The Pharma Data

AUGUST 3, 2021

Gilead Sciences, Inc. The Gilead Foundation, established in 2005, builds on the company’s longstanding commitment to supporting underserved communities around the world.

Science 52

Science International Disease 52

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2023

HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Hyman, Phelps & McNamara, P.C. (HP&M),

Marketing 59

Marketing Compliance Science FDA 59

Broad Institute

JANUARY 30, 2024

More bottles on the medicine shelf would help, but Bhattacharyya, who’s now also a research scientist, realized that science might lead to better tools for diagnosing and treating such challenging cases. FROM STARS TO CELLS Bhattacharyya’s interest in science began not in the lab, but in the sky.

Hospitals 137

Hospitals Virus Medical Schools Science 137

The Pharma Data

OCTOBER 23, 2020

Johnson pursued an education at Marshall University in Huntington, West Virginia, where he graduated with a Bachelor of Science in biology in 1977 and a Master of Science in microbiology in 1979. from 1993 to 2001 and the director of quality assurance at Sanofi Winthrop from 1992 to 1994. Source link.

Pharmaceuticals 52

Pharmaceuticals International Engineering Science 52

LifeSciVC

DECEMBER 5, 2024

With the closing of Fund XIV, we’re privileged to be able to continue backing innovative new biotech companies for another fund cycle, reinforcing our science-first and seed-led venture creation model for novel therapeutics – and delivering on our mission of doing well by doing good.

Marketing 76

Marketing RNA Science Drugs 76

Drug Target Review

FEBRUARY 28, 2024

from 2003 to 2006, covering the biotechnology and life-science tools sectors. Mr. Ho was an inductee into the McMaster University Alumni Gallery in 2020 and currently serves as a member of their Dean’s Advisory Board for the Faculty of Science. Chem Immunol Allergy 86:151-183 (2005). Science 294(5542):605-609 (2001).

Therapies 105

Therapies Engineering Molecular Biology Science 105

The Pharma Data

MARCH 13, 2021

Dr. Fei-Fei Li (44), a leading expert in artificial intelligence and Professor in the Computer Science Department at Stanford University in California, and Alberto Weisser (65), a renowned agricultural expert with decades of capital market experience in the United States. The independent candidates proposed for election are Prof.

International 52

International Engineering Science Marketing 52

Drug Target Review

MARCH 3, 2025

Meet Professor Jens Christian Schwamborn In 2002, Jens obtained a diploma in Biochemistry from the University of Witten/Herdecke in Germany and in 2005 a PhD in Biology from the University of Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna, Austria.

Disease 52

Disease Treatment Therapies Cell Biology 52

Drug Target Review

MAY 23, 2023

Credit: European Science Communication Institute The human microbiota is fundamental to correct functioning of tissue homeostasis, actively interacting with the host on different levels including mucosal surfaces of which the gastrointestinal tract is the most colonised. 2005) The role of the T cell in autoimmune inflammation, Arthritis Res.

Drugs 75

Drugs Small Molecule Production Disease 75

The Pharma Data

FEBRUARY 22, 2022

In 2005, he was appointed Senior Director of Oncology at Johnson & Johnson and in 2006, Executive Director of Oncology at Schering-Plough. About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Clinical Trials 52

Clinical Trials DNA Science Clinical Development 52

Alta Sciences

OCTOBER 9, 2024

PharmaVoice featured Dr. Setnik in an exclusive interview , highlighting her contributions to the life sciences field, and deeper insights into her visionary leadership and expertise. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Trials 40

The Pharma Data

NOVEMBER 5, 2020

First, we can beat COVID-19 with science, solutions and solidarity. R10 ) that strengthens Member States’ preparedness for health emergencies, such as COVID-19, through more robust compliance with the International Health Regulations (2005). [1] More than 47 million COVID-19 cases have now been reported to WHO, and more than 1.2

International 52

International Compliance Virus Vaccine 52

The Pharma Data

NOVEMBER 23, 2020

The investigation into the smuggling activities is being led by China’s ministry of science and technology along with related authorities. a biotech company focused on yeast-based antibody discovery, and served as president and CEO from 2000 to 2005. Human genetic goods are tightly regulated by the Chinese government.

Government 52

Government Molecular Biology Regulations Laboratories 52

The Pharma Data

MARCH 17, 2022

Sir Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: “The events of the past two years clearly show the need to push the boundaries of medical science has never been more urgent.

Science 40

Science Clinical Trials Disease Research 40

FDA Law Blog: Biosimilars

MAY 23, 2023

Since then, the science and legal and regulatory framework for food allergens have evolved considerably: Congress enacted the Food Allergen Labeling and Consumer Protection Act (2004) and the Food Safety Modernization Act (2011), and FDA implemented the regulatory requirements set forth in 21 C.F.R.

FDA 45

FDA Compliance Regulations Production 45

The Pharma Data

MARCH 11, 2021

The study was conducted in collaboration with Gilead Sciences, Inc. The antiviral medication Veklury was invented and developed by Gilead Sciences and is approved or authorized for temporary use for the treatment of COVID-19 in approximately 50 countries worldwide. Ltd and has been approved in Japan since April 2005.

Trials 52

Trials Hospitals Treatment Science 52

Sygnature Discovery

MARCH 24, 2022

The attraction of integration Originally from Kenya but a proud Yorkshirewoman – Leeds became her hometown at the age of 12 – Lynette gained her BSc in Pharmacology from the University of Sheffield in 2005. Back to Lynette, though. Alderley Park, where Lynette works for Sygnature So why Sygnature?

Computational Chemistry 52

Computational Chemistry International Science Pharmaceuticals 52

Translation

JULY 13, 2022

Measuring and modeling agricultural carbon sequestration through a microbial lens Dr. Debjani Sihi is an Assistant Professor at Emory University in the Department of Environmental Sciences. government targets to reduce greenhouse gas emissions by 50% below 2005 levels by 2030. She received the prestigious Gene E.

Regulations 52

Regulations Government Research International 52

Drug Target Review

DECEMBER 15, 2023

A Gates Scholar from the Medical Research Council Cognition and Brain Sciences Unit (MRC CBSU) at University of Cambridge Dr Jascha Achterberg said: “Not only is the brain great at solving complex problems, but it does also so while using very little energy. 2005 March 7 [2023 November 22]; 158(1):175-82. Behavioural Brain Research.

Medical Schools 69

Medical Schools Research Science Trials 69

Codon

JUNE 11, 2024

A partial solution to the problem came in 2005 when a team of researchers at the Scripps Institute found a “hacky” way to slow down the speed of nucleotides. Their solution was to fuse hairpins, little loops made from RNA or DNA, at various positions along the DNA strand that was being sequenced.

DNA 87

DNA Engineering RNA Small Molecule 87

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues. Tags Science and Health About Altasciences Weight 1

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

PLOS: DNA Science

APRIL 13, 2023

See The Age of the Pangenome Dawns , here at DNA Science from a few months ago.) The first SNP map was published in 2001 and the first GWAS in 2005. ” The post Genetic Signature for Drug Addiction Revealed in New Analysis of More Than A Million Genomes appeared first on DNA Science.

DNA 52

DNA Drugs Treatment Science 52

The Pharma Data

MAY 5, 2022

Launched in 2005 to give every child an equal chance of survival, ‘My Child Matters’ provides financial support and expertise so that all children can access diagnosis and treatment. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Vaccine 52

Vaccine Treatment Hospitals International 52

The Pharma Data

JANUARY 18, 2021

Fox Foundation continues to fund our cutting-edge science in their mission to transform the way new Parkinson’s disease treatments are developed and tested,” says Dr. Charlotte D’Hulst, CEO & Co-Founder of Yesse Technologies, Inc. “We are thrilled that The Michael J. View original content: [link]. Source link.

Disease 40

Disease Molecular Biology Licensing Licensing 40

The Pharma Data

NOVEMBER 22, 2021

State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem Sustainable environmental engineering aligned to Company’s zero carbon future.

Molecular Biology 52

Molecular Biology Laboratories Engineering Hospitals 52

Agency IQ

JANUARY 26, 2024

In response to this report, FDA researchers published extensive data on the SLEP program, reviewing the findings for 122 drugs products (3005 different lots) evaluated by the program between 1986 and 2005. The major takeaway: 88% (2560 lots) were extended beyond the original expiration date. “Of

Science 40

Science FDA Production Packaging 40

PLOS: DNA Science

JUNE 22, 2023

” Science journalists might better communicate drug mechanisms to consumers. She chronicled her journey in Glamour and in My So-Called Normal Life, a book published in 2005. It is a classic in medical science. The post How Targeted Cancer Drugs Disrupt the Cell Cycle appeared first on DNA Science. Blood cancer.

Drugs 52

Drugs Small Molecule DNA Clinical Trials 52

sptlabtech

JUNE 5, 2023

T he Chinese market is is very big very significant globally and we see the growth rates here are higher than most other markets around the world so it's a very important market for us and we're really pleased to be a really well established and leading brand in life science automation here.

Marketing 52

Marketing Production Science 52

SugarCone Biotech

MAY 28, 2019

A study, published in 2005, suggested that chloroquine could prevent SARS (the older virus) from infecting cells kept in culture. [2] Anti-vaccine sentiment offers an extreme example of Science Denialism, and its adherents have many and complicated ways of rationalizing their views built for example on religious, political and cultural mores.

Vaccine 52

Vaccine Clinical Trials Virus Science 52

The Pharma Data

DECEMBER 14, 2020

Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. About Burning Rock. 2 Woodard et al., 2020 North America International Association for the Study of Lung Cancer Conference Poster.

Licensing 52

Licensing Licensing Pharmaceutical Companies Treatment 52

The Pharma Data

OCTOBER 20, 2020

To complement the clinical focus of the annual SABCS®, Baylor College of Medicine became a joint sponsor of SABCS® in 2005. The Symposium is attended by a large international audience of researchers, health professionals, physicians, oncologists, and those with a special interest in breast cancer from over 90 countries.

Treatment 40

Treatment Research International Regulations 40

The Pharma Data

OCTOBER 21, 2020

22, 2020 (GLOBE NEWSWIRE) — Abcam plc (AIM: ABC) (“ Abcam ”), a global leader in the supply of life science research tools, announces today the pricing of its offering of 8,945,218 American Depositary Shares (“ ADSs ”), representing an aggregate of 8,945,218 ordinary shares, at a price of $17.50 LONDON, Oct.

Regulations 40

Regulations Marketing Science Research 40

The Pharma Data

DECEMBER 15, 2020

“We are thrilled that Diamyd Medical is taking a leading role and championing precompetitive collaborations advancing type 1 diabetes regulatory science solutions”, said Inish O’Doherty Executive Director at C-Path. About Critical Path Institute.

Drug Development 40

Drug Development Clinical Trials Trials Vaccine 40

DrugBank

JUNE 27, 2023

Conclusion Since the first GWAS was published in 2005, there have been more than 50,000 significant variant-trait associations identified. How data science and AI-based technologies impact genomics. Making 40 , 924–938 (2020).  MacEachern, S. & Forkert, N. Machine learning for precision medicine.  Lin, J. &

Disease 98

Disease Treatment Drugs Clinical Trials 98

Metabolite Tales Blog

MARCH 1, 2023

1994, 22, 659-662 [link] 18a Xenobiotica , 1986, 16, 11-20 [link] 18b Wood and Fibre Science. 2009, 41, 157-167 [link] 19 Molecules. 2020, 25, 4309 [link] 20 Drug Metab. 2013, 41, 508-517 [link] 21 J. 2010, 75, 9, 3141–3143 [link] 22 Clin Pharmacokinet.

Metabolic Stability 52

Metabolic Stability Drugs Pharmacokinetics Science 52

Agency IQ

JANUARY 19, 2024

Therefore, the push and pull of the background science that underlies the primary or secondary NAAQS is extremely important, and what studies the agency chooses to base its regulations off may have a significant effect on the regulations themselves. The EPA initiated a new review for oxides of sulfur and nitrogen in 2005.

Regulations 40

Regulations Science Government Research 40

The Pharma Data

NOVEMBER 9, 2020

For more than two decades, Amgen has been committed to advancing the science and the understanding around inflammation to address the unmet patient needs that exist and expanding our portfolio. We lead with science through discovery research that is disease-agnostic and biology-first, modality-second. 2005; 172; 149–60.

Trials 52

Trials Production Clinical Trials Government 52